Picture of Seer logo

SEER Seer Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m+10.56%
3m-1.49%
6m+13.11%
1yr+9.61%
Volume Change (%)
10d/3m+29.25%
Price vs... (%)
52w High-24.95%
50d MA-2.36%
200d MA-2.92%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-28.5%
Return on Equity-23.91%
Operating Margin-706.43%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Seer EPS forecast chart

Profile Summary

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
March 16th, 2017
Public Since
December 4th, 2020
No. of Shareholders
32
No. of Employees
134
Sector
Office Equipment
Industry
Technology
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
59,782,035

SEER Share Price Performance

Upcoming Events for SEER

Q1 2025 Seer Inc Earnings Release

Seer Inc Annual Shareholders Meeting

Q2 2025 Seer Inc Earnings Release

Similar to SEER

Picture of Xerox Holdings logo

Xerox Holdings

us flag iconNASDAQ Global Select Market

FAQ